×
To start your customized experience click the start button
Customize ?  
Start
Cancer Types
Quick Links
Award Programs
About Us
Careers
Contact Us
Newsroom
Privacy Policy
Terms & Conditions
 
Twitter
Face Book
YouTube
Instagram
 
 
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2018
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

cureTV – Empowering Patients Through Video

Sponsored Content
Watch a video about Chad, a patient using Optune. Learn how Chad manages his treatment while enjoying his favorite activities.
Arjun V. Balar, M.D.
An expert discusses the future of immunotherapy in light of new frontline treatments like Keytruda that have been demonstrating positive results for patients with non–muscle invasive bladder cancer.
Mark Socinski, M.D.
Thanks to better understanding of cancer biology, the outlook for advanced lung cancer is better than it has ever been.
Jean Diesch
Any action, larger or small, can make a major impact in the lives of patients with a myeloproliferative neoplasm.
Jarushka Naidoo, M.B.B.Ch.
Immunotherapy can cause some side effects that patients and practitioners should look out for.
Sumanta K. Pal, M.D.
Yervoy plus Opdivo is a good combination for many patients with kidney cancer, though some individuals should steer clear of the regimen.
Celia Miltz
After her daughter was diagnosed, Celia Miltz founded the Friends of ET Research.
Angela Fleischman, M.D., Ph.D.
Angela Fleischman, M.D., Ph.D., is particularly excited for improvements in treating early-stage disease.
Richard French
After realizing how little awareness there was about MPNs, one advocate looked to his TV background to help.
Jaden Persaud
Jaden Persaud knows firsthand how a MPN diagnosis can affect a family's life.
×
×

Sign In

Not a member? Sign up now!
Continue without login
Continue
×

Sign Up

Patient Caregiver Advocate Other